tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

VALN Stock Latest News

Valneva’s Chikungunya Vaccine Restriction Lifted by EMA
Company AnnouncementsValneva’s Chikungunya Vaccine Restriction Lifted by EMA
17d ago
6K
VALN
Valneva Partners with CSL Seqirus for Vaccine Distribution in Germany
PremiumCompany Announcements
Valneva Partners with CSL Seqirus for Vaccine Distribution in Germany
1M ago
6K
VALN
Valneva Confirms 2025 Guidance Following Successful AGM
PremiumCompany Announcements
Valneva Confirms 2025 Guidance Following Successful AGM
1M ago
6K
VALN
UK restricts use of Valneva chikungunya vaccine for safety review
PremiumThe Fly
UK restricts use of Valneva chikungunya vaccine for safety review
2M ago
VALN
Valneva drops 2% to $6.05 after UK restricts vaccine use
PremiumThe Fly
Valneva drops 2% to $6.05 after UK restricts vaccine use
2M ago
VALN
Valneva Announces Positive Phase 2 Results for Chikungunya Vaccine in Children
PremiumCompany AnnouncementsValneva Announces Positive Phase 2 Results for Chikungunya Vaccine in Children
2M ago
6K
VALN
Valneva says IXCHIQ ‘well tolerated’ by children ages 1-11 years
Premium
The Fly
Valneva says IXCHIQ ‘well tolerated’ by children ages 1-11 years
2M ago
VALN
Valneva Prepares for Shareholder Meeting and Announces Leadership Change
Premium
Company Announcements
Valneva Prepares for Shareholder Meeting and Announces Leadership Change
2M ago
6K
VALN
Valneva to Engage with Investors at June Conferences
PremiumCompany Announcements
Valneva to Engage with Investors at June Conferences
2M ago
6K
VALN
Valneva’s Chikungunya Vaccine Use Paused for Elderly Amid Safety Review
PremiumCompany Announcements
Valneva’s Chikungunya Vaccine Use Paused for Elderly Amid Safety Review
3M ago
6K
VALN
Valneva price target lowered to $14 from $15 at Guggenheim
PremiumThe Fly
Valneva price target lowered to $14 from $15 at Guggenheim
3M ago
VALN
Valneva SE Reports Strong Q1 2025 Revenue Growth
PremiumCompany Announcements
Valneva SE Reports Strong Q1 2025 Revenue Growth
3M ago
VALN
Valneva Reports Strong Q1 2025 Results and Advances Vaccine Portfolio
PremiumCompany AnnouncementsValneva Reports Strong Q1 2025 Results and Advances Vaccine Portfolio
3M ago
6K
VALN
Valneva says EMA started Ixchiq review after reports of SAEs
Premium
The Fly
Valneva says EMA started Ixchiq review after reports of SAEs
3M ago
VALN
Valneva’s Chikungunya Vaccine Use Suspended for Elderly Amid Safety Concerns
Premium
Company Announcements
Valneva’s Chikungunya Vaccine Use Suspended for Elderly Amid Safety Concerns
3M ago
6K
VALN
Valneva’s Chikungunya Vaccine Receives Updated ACIP Recommendation Amid Safety Review
PremiumCompany Announcements
Valneva’s Chikungunya Vaccine Receives Updated ACIP Recommendation Amid Safety Review
3M ago
6K
VALN
Valneva Showcases Chikungunya Vaccine at World Vaccine Congress
PremiumCompany Announcements
Valneva Showcases Chikungunya Vaccine at World Vaccine Congress
3M ago
6K
VALN
Valneva’s Vaccine Approval and Strategic Partnerships Drive Buy Rating with Promising Financial Projections
PremiumRatings
Valneva’s Vaccine Approval and Strategic Partnerships Drive Buy Rating with Promising Financial Projections
3M ago
VALN
Valneva’s Chikungunya Vaccine Gains First Approval in Brazil
PremiumCompany Announcements
Valneva’s Chikungunya Vaccine Gains First Approval in Brazil
4M ago
6K
VALN
Valneva granted marketing authorization for Ixchiq in Brail
PremiumThe FlyValneva granted marketing authorization for Ixchiq in Brail
4M ago
VALN
Positive Outlook for Valneva Driven by Promising Vaccine Pipeline and Strategic Developments
Premium
Ratings
Positive Outlook for Valneva Driven by Promising Vaccine Pipeline and Strategic Developments
4M ago
VALN
Valneva and LimmaTech Initiate Phase 2 Study of Shigella Vaccine
Premium
Company Announcements
Valneva and LimmaTech Initiate Phase 2 Study of Shigella Vaccine
4M ago
6K
VALN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >